Linde PLC $LIN Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC trimmed its holdings in Linde PLC (NASDAQ:LIN) by 5.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 50,820 shares of the basic materials company’s stock after selling 3,157 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Linde were worth $24,140,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Darwin Wealth Management LLC purchased a new stake in Linde during the second quarter worth $25,000. Marquette Asset Management LLC purchased a new position in shares of Linde in the third quarter valued at approximately $27,000. YANKCOM Partnership lifted its holdings in Linde by 195.2% in the 3rd quarter. YANKCOM Partnership now owns 62 shares of the basic materials company’s stock valued at $29,000 after purchasing an additional 41 shares in the last quarter. Albion Financial Group UT boosted its stake in Linde by 87.8% during the 3rd quarter. Albion Financial Group UT now owns 77 shares of the basic materials company’s stock worth $37,000 after purchasing an additional 36 shares during the last quarter. Finally, Howard Hughes Medical Institute acquired a new stake in shares of Linde in the second quarter valued at about $48,000. Hedge funds and other institutional investors own 82.80% of the company’s stock.

Linde Trading Up 1.3%

Shares of Linde stock opened at $451.57 on Monday. The stock has a 50 day moving average of $421.73 and a 200 day moving average of $448.14. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.69 and a current ratio of 0.82. The firm has a market capitalization of $210.86 billion, a price-to-earnings ratio of 30.25, a PEG ratio of 3.17 and a beta of 0.85. Linde PLC has a fifty-two week low of $387.78 and a fifty-two week high of $486.38.

Linde (NASDAQ:LIN) last announced its quarterly earnings results on Friday, October 31st. The basic materials company reported $4.21 EPS for the quarter, beating the consensus estimate of $4.18 by $0.03. Linde had a return on equity of 19.38% and a net margin of 21.17%.The business had revenue of $8.62 billion for the quarter, compared to analyst estimates of $8.62 billion. During the same quarter in the prior year, the company posted $3.94 EPS. The company’s quarterly revenue was up 2.9% on a year-over-year basis. Linde has set its FY 2025 guidance at 16.350-16.450 EPS and its Q4 2025 guidance at 4.100-4.200 EPS. As a group, research analysts predict that Linde PLC will post 16.54 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. BMO Capital Markets set a $501.00 price target on shares of Linde in a research report on Wednesday, December 17th. Citigroup raised their target price on shares of Linde from $520.00 to $540.00 and gave the stock a “buy” rating in a research note on Wednesday, January 21st. Weiss Ratings restated a “hold (c+)” rating on shares of Linde in a research report on Monday, December 29th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $516.00 price target on shares of Linde in a report on Monday, November 3rd. Finally, CICC Research assumed coverage on Linde in a research note on Wednesday, December 3rd. They set an “outperform” rating and a $510.00 price objective on the stock. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $501.75.

Linde Company Profile

Linde (NASDAQ: LIN) is a multinational industrial gases and engineering company that supplies gases, related technologies and services to a wide range of industries. The company traces its current form to the 2018 combination of Germany’s Linde AG and U.S.-based Praxair, creating one of the largest global providers of industrial, specialty and medical gases. Linde’s business model centers on production, processing and distribution of gases as well as the design and construction of the plants and equipment needed to produce them.

Core products and services include atmospheric and process gases such as oxygen, nitrogen and argon; hydrogen and helium; carbon dioxide; and a portfolio of higher‑value specialty and electronic gases.